23andMe | Investor Presentation Deck | 39 slides · page 8 of 39
The slide uses a '2x-3x' metric to justify the value of genetic support in drug discovery, citing Nelson et al. (2015) and King et al. (2019).
Pitch deck · competitive_analysis · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 legend 1/1 source-note 1/1 table 1/1 title 1/1
Components 5
primary legend source-note data headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1